Search for: "GLAXOSMITHKLINE"
Results 81 - 100
of 1,808
Sort by Relevance
|
Sort by Date
30 Aug 2021, 10:58 am
Sotrovimab, the newest antibody therapy, was developed by GlaxoSmithKline and Vir Biotechnology after a large collaborative study by scientists from across the nation discovered a natural antibody (in the blood of a SARS survivor, back in 2003) that has remarkable breadth and efficacy. [read post]
24 Aug 2021, 2:10 am
Teva GlaxoSmithKline LLC v. [read post]
19 Aug 2021, 6:00 am
GlaxoSmithKline v. [read post]
13 Aug 2021, 6:43 am
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, No. 20-cv-09077-JSW, 2021 WL 3524047 (N.D. [read post]
12 Aug 2021, 8:59 pm
By Kevin E. [read post]
6 Aug 2021, 11:15 am
Court of Appeals for the Federal Circuit (CAFC) on Thursday underscored its October 2020 ruling that generic company, Teva Pharmaceuticals, was liable for induced infringement of GlaxoSmithKline’s (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol. [read post]
6 Aug 2021, 11:15 am
Court of Appeals for the Federal Circuit (CAFC) on Thursday underscored its October 2020 ruling that generic company, Teva Pharmaceuticals, was liable for induced infringement of GlaxoSmithKline’s (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol. [read post]
5 Aug 2021, 12:12 pm
GlaxoSmithKline LLC v. [read post]
5 Aug 2021, 8:10 am
GlaxoSmithKline v. [read post]
2 Aug 2021, 6:12 am
U.S. share of H1 global activity (59% of all campaigns) remains elevated relative to 2020 levels (44% of all campaigns) and in line with historical levels The 55 U.S. campaigns initiated in H1 2021 represent a 31% increase over the prior-year period After only initiating one new campaign in Q1 2021, Elliott launched five campaigns in Q2 2021 and returned to being the period’s most prolific activist H1 2021 activity in Europe slowed following a record-setting end to 2020; the region’s 21… [read post]
14 Jul 2021, 8:09 pm
The background of the opinion describes the rather complex set of issues: We describe the facts in the light most favorable to the party that won the jury verdict (here, the plaintiffs). [read post]
25 Jun 2021, 4:15 am
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
15 Jun 2021, 8:04 am
Meads in a whistleblower case against pharmaceutical giant GlaxoSmithKline that led to the drug company agreeing to pay the government $750 million to settle civil and criminal charges that it manufactured and sold... [read post]
28 May 2021, 11:49 am
According to the recent decision of Singh v Glaxosmithkline Inc,[i] a proposed representative plaintiff does have such a right. [read post]
18 May 2021, 5:00 pm
The Wall Street Journal notes some examples, including GlaxoSmithKline acquiring Stifle Laboratories and Grifols acquiring Talecris Biotherapeutics. [read post]
17 May 2021, 2:09 pm
The vaccine developed by pharmaceutical companies Sanofi and GlaxoSmithKline reported positive results from clinical trials on Monday, indicating the vaccine could be added to the global vaccine supply, according to France24. [read post]
7 May 2021, 9:13 am
” And GlaxoSmithKline shows ads for Trelegy, a $600-per-month inhaler, if someone was flagged by Facebook for “chronic obstructive pulmonary disease [COPD] awareness. [read post]
21 Apr 2021, 6:11 am
Take a recent case, In re Zofran, involving allegations that GlaxoSmithKline (GSK) sold the drug Zofran while knowing it caused severe birth defects. [read post]
19 Apr 2021, 10:56 am
Recently, scientists reported dangerous carcinogens in the over-the-counter heartburn drug Zantac and its generic form ranitidine. [read post]
18 Mar 2021, 11:38 am
Actualmente, existe una demanda activa contra GlaxoSmithKline, una empresa farmacéutica responsable de Zofran. [read post]
